Background: Delivery of pathology reports to the patient is a key step in the biopsy pathway, which is important for patient safety in dermatology. Automated systems for facilitating such medical process began in 2010 in our hospital, sending short message service to scheduled patients. Objective: The purpose of this study was to evaluate the delivery of pathology reports to patients and investigate factors that influence this process and annual trends. Methods: We retrospectively reviewed the medical records of all outpatients (n=2,452) who underwent skin biopsy at our department of dermatology in 2009 and 2014. In each year group, we analyzed the proportion of revisiting patients in terms of year, sex, age, season, biopsy method and diagnosis. Results: In 2009, a smaller proportion of patients (205; 91.5%) who had undergone shave or excisional biopsy than of those who had undergone punch biopsy returned (781; 98.0%; p＜0.001).
INTRODUCTION
Skin biopsy is the most common and critical test in determining the diagnosis and etiology of skin diseases. Biopsy quality involves several aspects (test site, proficiency of the physician, quality and preservation of the sample, and proficiency of the pathologist), and each aspect is important to the quality of the entire test 1, 2 .
However, even if all of the above aspects are satisfactory, the ultimate purpose of the test can only be fulfilled when the pathology test results are delivered to the dermatology staff within an appropriate time period, and when the information is then delivered to the patient. It is the clinician's ethical responsibility to deliver the test results to the patient promptly, especially if the results indicate a malignant tumor or the need for a surgical resection. Because telemedicine is prohibited in South Korea except for specific conditions (prison and backwoods), return visit of patients is essential for delivery of test results. To the best of our knowledge, apart from one study in an Israeli hospital 3 , few studies have examined the delivery of pathology test results from the perspective of patient safety. Advances in data-processing equipment have provided medical staff with easier access to patients' test results. In this regard, SMG-SNU Boramae Medical Center began to Values are presented as number (%) or mean±standard deviation. *Degree of freedom, † t-value. Values are presented as number (%) or mean±standard deviation. *Degree of freedom, † t-value. (Fig. 2) .
Investigation on critical patient drop out
There were three critical patients with malignancy or malignancy suspected lesion who did not return to dermatology clinics. The first patient was a 76-year-old woman who consulted to the dermatology clinic regarding multiple papules in the neck that had occurred during treatment and follow-up at the hemato-oncology clinic. Her pathology test results indicated leukemia cutis due to T-cell large granular lymphocytic leukemia. She did not revisit the appointed dermatology clinic, but later continued treatment at Internal Medicine via radiation therapy based on the pathology test results. The second patient was a 59-year-old man who visited our department because of a nodular lesion in the right finger that had recurred after a surgical removal at another hospital. After biopsy at our department, the patient received the test results of proliferation of spindle cells with a mitotic index of 4 mitotic figures per 10 high power fields requiring a complete resection at the plastic surgery department and the physician recommended surgical resection but the patient did not comply with the follow-ups. The third patient was a 79-year-old man with erythematous plaque, nodules, and papules in the scrotum and penis region. His pathology test indicated extramammary Paget's disease. After the biopsy, the patient did not revisit the dermatology clinic at his scheduled appointment, and he did not seek treatment. He revisited one year later when the lesion became aggravated. We referred the patient to urology and he underwent a wide resection.
DISCUSSION
In 2000, a report was published by the Institute of Medicine addressing the situation regarding patient safety and suggesting some improvements 2 . This has sparked societal interest in patient safety. Medical errors, such as medication errors, surgical errors, anesthetic errors, intra-hospital infections, fall injuries, and misdiagnoses, are critically related to patient safety. Such mistakes may result from errors in medical judgment, procedures, or equipment, as well as in physician-patient communication. Therefore, it is essential that the physician communicate effectively with the patient, not only to ensure the quality of health management, but also to improve the patient's health outcomes 5 . In dermatology clinics, skin biopsies are critically important in cases where definitive diagnosis cannot be made on the basis of the patient's medical history and clinical findings alone. The procedure is also essential in determining treatment direction and consultation with the patient. In other countries such as America and Britain, more than half of patients who had undergone a skin biopsy to diagnose potential malignant tumors preferred to receive the results through the quickest method (phone consultation) 6 and 30% of patients suffered from mental stress waiting for the results, regardless of whether the tumor is malignant or not 7 . Therefore, timely and prompt delivery of pathology test results is essential in terms of patient safety. However, skin biopsies inevitably involve the following processes: slide production, pathologist's reading and findings, and delivery of these findings to the dermatology clinic. Subsequently, the results can be relayed to the patient. In the past, it was difficult to view and track the test procedures performed by medical staff, because all medical information was recorded on paper 8, 9 .
Our hospital computerized all medical records in 2010, but the efficiency of electronic system has not yet been surveyed. In the present study, the proportion of patients who revisited after skin biopsy was about 97%-higher than in another study from a dermatology clinic at a tertiary hospital in Israel, where the proportion of patients who revisited increased from 90% to 97% only after the hospital had implemented measures to enhance the quality of medical care. This included patient education through face-to-face instruction by medical staff emphasizing how important it is that pathology test results are delivered to patients, and that patients revisit the hospital. Moreover, the Israeli hospital implemented a computerized system to enable medical staff to regularly monitor test results within two weeks 3 .
The proportion of patients who revisited depended on certain factors. First, in 2014, a higher proportion of women than men revisited. Choi et al. 11 reported that about 90%
of Koreans have heard about skin cancer, and that women are about twice as aware of the illness as men. Coupled with the growing interest in dermatological disorders over time, this may have contributed to the higher revisit ratio among women. In addition, they may want a more definitive diagnosis of skin cancer or other skin disorders, and they wish to consult with their physicians regarding treatment procedures. Second, the revisit ratio also differed significantly in terms of the method of skin biopsy. In 2009, the revisit ratio was lower when either a shave biopsy or an excisional biopsy was performed and the entire lesion was removed. However, there was no such difference in 2014. This implies that patients were more focused on the removal of lesions in the past, and that over time they have become more interested in an accurate diagnosis of their skin disorders. Several changes were made in our hospital between 2009 and 2014. First, electronic medical record system was introduced to our hospital in January 2010. Such system enabled medical staff to immediately confirm which medical care or test procedures were performed and to view test results quickly without additional processes. Second, our hospital also had implemented an automated text message system to remind patients of their revisit schedules since 2010. This automated notification system was not specific for dermatology clinic, but generalized for patients who had been scheduled for visiting our hospital. The message is sent 3 days before scheduled date, and it included date, time, clinic department and name of attending clinician in Korean. Statistical analysis of the 2009 and 2014 data did not show a significant difference in the revisit ratios; however, the absolute numbers of patients who did not revisit in 2009 and 2014 were similar, even though the number of patients who underwent skin biopsy in 2014 had increased by 1.4 times. This implies that the automated message systems may have contributed to patient revisits to a certain extent, but additional studies would be required to confirm such conclusions. There were three crucial patients who did not revisit the dermatologic clinic even though their lesions required further management. Fortunately, two of them were able to receive the test results through medical staff at different departments. However, in the case of the third patient, the test results were not delivered to the patient and the hospital had failed to track him, which undermined his safety with his aggravated condition that might have caused treatment difficulties. Therefore, we recommend an organized system to ensure more rigorous management of patient safety; (1) recording patients' medical record number, test date, and biopsy method in the biopsy records that the department itself manages, and (2) regularly recording the pathology test results and patients' revisit status. A computerized biopsy records would be much easier for staffs to administer, in this case. In addition to these internal efforts by the dermatology clinic, additional measures by the hospital should be considered, such as an automated text messaging system which not only reminds patients of simple schedule but also notifies of the presence of tests results to be delivered. Furthermore, an automated system can also inform attending physicians of critical abnormal findings in the biopsy results. Some of the limitations of this study include simplified comparison between benign and malignant lesions. A part of benign skin lesions such as actinic keratosis need further treatment and patient should know their real nature. However, as criteria for simple benign lesions and the others requiring further treatment are practically subjective and variable, we classified according to existence of atypical or malignant cells. We could not investigate the attitude of the patients or their caregivers to the system due to the retrospective study design and further studies are required.
In conclusion, this study analyzed 2,452 patients who took skin biopsy at our dermatology clinics in 2009 and 2014 for revisit ratio after skin biopsy and influencing factors. Most of patients (96.8%) returned clinics and their pathology results were delivered. Whereas sex and the method of skin biopsy influenced revisit ratio, age at biopsy, date, and pathology test results did not make significant difference. Female patients or patients with partial lesion removal through biopsy were more willing to revisit after skin biopsy. There were critical cases that failed in result delivery and follow-up in our department, which required improvement from the perspective of patient safety. In addition to dermatologists' own efforts, improved computerization system of the hospital enabling to trace test results should be considered for better patient management.
